Spot Trading’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.25M Buy
37,800
+11,100
+42% +$384K 0.02% 1001
2017
Q2
$893K Sell
26,700
-2,900
-10% -$86.5K 0.02% 1182
2017
Q1
$857K Sell
29,600
-8,400
-22% -$208K 0.03% 848
2016
Q4
$849K Buy
38,000
+32,600
+604% +$637K 0.02% 1061
2016
Q3
$100K Sell
5,400
-27,400
-84% -$517K ﹤0.01% 2411
2016
Q2
$535K Buy
32,800
+9,700
+42% +$143K 0.01% 1576
2016
Q1
$270K Buy
+23,100
New +$258K ﹤0.01% 2013
2015
Q4
Sell
-28,200
Closed -$345K 4494
2015
Q3
$345K Sell
28,200
-9,600
-25% -$122K ﹤0.01% 2316
2015
Q2
$356K Buy
+37,800
New +$350K ﹤0.01% 2337
2014
Q1
Sell
-30,000
Closed -$238K 4829
2013
Q4
$238K Hold
30,000
﹤0.01% 2923
2013
Q3
$297K Buy
+30,000
New +$236K ﹤0.01% 2761

Other funds holding BEAT

Spot Trading's BEAT Position: Q4 2016 in Review

Spot Trading sold out of BioTelemetry, Inc. (BEAT) in Q4 2016, closing a stake of 5,100 shares — an estimated $99.7K sold.

Spot Trading first reported a position in BEAT in Q2 2016 and held it in 2 quarters. The position peaked at $95K in Q3 2016. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

  • Spot Trading reported no remaining BioTelemetry, Inc. position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 5,100 BioTelemetry, Inc. shares in Q4 2016, an estimated $99.7K.
  • Spot Trading first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 2 quarters.
  • Spot Trading's BioTelemetry, Inc. position peaked at $95K in Q3 2016.
  • 160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.